1. Home
  2. GUG vs SIBN Comparison

GUG vs SIBN Comparison

Compare GUG & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GUG
  • SIBN
  • Stock Information
  • Founded
  • GUG 2021
  • SIBN 2008
  • Country
  • GUG United States
  • SIBN United States
  • Employees
  • GUG N/A
  • SIBN N/A
  • Industry
  • GUG Trusts Except Educational Religious and Charitable
  • SIBN Medical/Dental Instruments
  • Sector
  • GUG Finance
  • SIBN Health Care
  • Exchange
  • GUG Nasdaq
  • SIBN Nasdaq
  • Market Cap
  • GUG 524.4M
  • SIBN 606.1M
  • IPO Year
  • GUG N/A
  • SIBN 2018
  • Fundamental
  • Price
  • GUG $15.78
  • SIBN $15.57
  • Analyst Decision
  • GUG
  • SIBN Strong Buy
  • Analyst Count
  • GUG 0
  • SIBN 5
  • Target Price
  • GUG N/A
  • SIBN $24.60
  • AVG Volume (30 Days)
  • GUG 108.9K
  • SIBN 424.4K
  • Earning Date
  • GUG 01-01-0001
  • SIBN 11-10-2025
  • Dividend Yield
  • GUG 9.67%
  • SIBN N/A
  • EPS Growth
  • GUG N/A
  • SIBN N/A
  • EPS
  • GUG N/A
  • SIBN N/A
  • Revenue
  • GUG N/A
  • SIBN $185,262,000.00
  • Revenue This Year
  • GUG N/A
  • SIBN $19.96
  • Revenue Next Year
  • GUG N/A
  • SIBN $16.24
  • P/E Ratio
  • GUG N/A
  • SIBN N/A
  • Revenue Growth
  • GUG N/A
  • SIBN 22.93
  • 52 Week Low
  • GUG $12.71
  • SIBN $11.70
  • 52 Week High
  • GUG $15.06
  • SIBN $20.05
  • Technical
  • Relative Strength Index (RSI)
  • GUG 48.94
  • SIBN 55.44
  • Support Level
  • GUG $15.42
  • SIBN $15.13
  • Resistance Level
  • GUG $15.83
  • SIBN $15.76
  • Average True Range (ATR)
  • GUG 0.27
  • SIBN 0.62
  • MACD
  • GUG -0.02
  • SIBN 0.11
  • Stochastic Oscillator
  • GUG 41.48
  • SIBN 72.76

About GUG Guggenheim Active Allocation Fund of Beneficial Interest

Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

Share on Social Networks: